Gallium-68 in Medical Imaging.

Area of Science:

• Nuclear medicine
• Radiochemistry
• Medical imaging

Background:

• Positron Emission Tomography (PET) imaging has seen increased adoption of Gallium-68 (68Ga) labeled agents.
• 68Ga is readily available from a germanium-68/gallium-68 (68Ge/68Ga) generator, offering convenience and potentially lower costs compared to cyclotron-produced radioisotopes.
• The 68-minute half-life of 68Ga is suitable for various PET imaging procedures while maintaining acceptable patient radiation doses.

Purpose of the Study:

• To summarize the growing clinical applications of 68Ga-based radiotracers in medical imaging.
• To highlight the advantages of using 68Ga for PET imaging, including its production method and pharmacokinetic properties.

Main Methods:

• Review of emerging clinical utilization of 68Ga-based radiotracers.
• Summary of the benefits of 68Ga production via 68Ge/68Ga generators.
• Discussion of the suitable half-life of 68Ga for PET imaging.

Main Results:

• Significant increase in the clinical use of 68Ga-labeled PET imaging agents.
• Cost-effectiveness and ease of use associated with 68Ge/68Ga generators for 68Ga production.
• Adequate radioactivity and acceptable radiation doses for patients using 68Ga.

Conclusions:

• 68Ga-based radiotracers represent a valuable and expanding tool in clinical nuclear medicine.
• The accessibility and favorable characteristics of 68Ga facilitate its widespread application in PET imaging.
• Emerging clinical utilization underscores the importance of 68Ga in modern medical diagnostics.